Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-10 Option Award | 2025-02-12 8:16 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 1,090,460 | $0 | 1,090,460 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 15,405 | $2.56 | 276,829 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 30,397 | $0 | 276,829 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 4:40 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 546,341 | $0 | 546,341 (Direct) | View |
| 2024-01-31 Tax Withholding | 2024-02-02 7:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 26,835 | $3.36 | 185,838 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 70,745 | $0 | 185,838 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 9:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 30,397 | $0 | 248,324 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 9:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 10,511 | $5.02 | 248,324 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 7:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 70,744 | $0 | 192,787 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-28 8:58 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 141,489 | $0 | 141,489 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-04 9:49 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 7,598 | $0 | 188,091 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 9:05 pm | N/A 2032-03-23 | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-13 4:15 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 17,242 | $0 | 188,091 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 8:34 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 7,598 | $0 | 188,091 (Direct) | View |
Ownership(A) | 2021-04-05 5:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 0 | $0 | 18,860 (Direct) | View |
Ownership | 2021-03-11 9:49 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 0 | $0 | 169,231 (Direct) | View |